Ammonium molybdate

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Ammonium molybdate
DrugBank Accession Number
DB11128
Background

Ammonium molybdate is a source of molybdenum that exists in several hydrate forms. It is intravenously administered as an additive to solutions for Total Parenteral Nutrition (TPN). Molybdenum is an essential element that is present in enzymes including xanthine oxidase, sulfite oxidase, and aldehyde oxidase.

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 1235.92
Monoisotopic: 1249.464289
Chemical Formula
H32Mo7N6O28
Synonyms
  • Ammonium molybdate
  • Ammonium molybdate tetrahydrate
  • Ammonium molybdate(VI) tetrahydrate
  • Ammonium paramolybdate tetrahydrate
  • Hexaammonium heptamolybdate tetrahydrate
  • Hexaammonium molybdate tetrahydrate
  • Molybdenum (as ammonium molybdate)

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Associated Conditions
Indication TypeIndicationCombined Product DetailsApproval LevelAge GroupPatient CharacteristicsDose Form
Used in combination to treatAnemia of pregnancyCombination Product in combination with: Nicotinamide (DB02701), Riboflavin (DB00140), Vitamin D (DB11094), Ferrous fumarate (DB14491), Folic acid (DB00158), Menadione (DB00170), Thiamine (DB00152), Calcium lactate (DB13231)••• •••••••••• ••••••
Used in combination to preventAnemia, perniciousCombination Product in combination with: Nicotinamide (DB02701), Ferrous gluconate (DB14488), Ascorbic acid (DB00126), Cholecalciferol (DB00169), Calcium Phosphate (DB11348), Thiamine (DB00152), Calcium lactate (DB13231), Riboflavin (DB00140), Menadiol diphosphate (DB14650)••• •••••••••• ••••••
Used in combination to treatAnemia, perniciousCombination Product in combination with: Ferrous gluconate (DB14488), Riboflavin (DB00140), Ascorbic acid (DB00126), Calcium Phosphate (DB11348), Calcium lactate (DB13231), Thiamine (DB00152), Menadiol diphosphate (DB14650), Cholecalciferol (DB00169), Nicotinamide (DB02701)••• •••••••••• ••••••
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Active Moieties
NameKindUNIICASInChI Key
MolybdateionicO0L10E635214259-85-9MEFBJEMVZONFCJ-UHFFFAOYSA-N
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Ammonium MolybdateInjection, solution46 ug/1mLIntravenousAmerican Regent1990-09-302013-03-01US flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Ammonium MolybdateAmmonium molybdate (46 ug/1mL)Injection, solutionIntravenousAmerican Regent1990-09-302013-03-01US flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
OGI154X474
CAS number
12054-85-2
InChI Key
FZDJSHPVOMNEIF-UHFFFAOYSA-T
InChI
InChI=1S/7Mo.6H3N.4H2O.24O/h;;;;;;;6*1H3;4*1H2;;;;;;;;;;;;;;;;;;;;;;;;/q7*+6;;;;;;;;;;;24*-2/p+6
IUPAC Name
heptamolybdenum(6+) hexaammonium tetrahydrate tetracosaoxidandiide
SMILES
[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].[NH4+].O.O.O.O.[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[Mo+6].[Mo+6].[Mo+6].[Mo+6].[Mo+6].[Mo+6].[Mo+6]

References

General References
Not Available
PubChem Compound
485454
PubChem Substance
347827909
ChemSpider
32700613
RxNav
17789
Wikipedia
Ammonium_molybdate

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1Not Yet RecruitingOtherProstate Cancer1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Injection, solutionIntravenous46 ug/1mL
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP-0.98Chemaxon
pKa (Strongest Basic)8.86Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count0Chemaxon
Hydrogen Donor Count1Chemaxon
Polar Surface Area0 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity16.31 m3·mol-1Chemaxon
Polarizability2.38 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at December 03, 2015 16:51 / Updated at February 21, 2021 18:52